Evoke Pharma

EVOK NASDAQ
0.5680
-0.0320
-5.33%
After Hours: 0.5900 +0.022 +3.87% 17:52 05/24 EDT
Open
0.6000
Prev Close
0.6000
High
0.6024
Low
0.5680
Volume
272.52K
Avg Vol (3M)
970.36K
52 Week High
3.400
52 Week Low
0.5300
% Turnover
1.17%
Market Cap
13.21M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Company Profile

Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The Company is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. EVK-001 is a formulation of Metoclopramide drug, designed to provide systemic delivery of metoclopramide through intranasal administration. The Company has evaluated EVK-001 in a multicenter, randomized, double-blind, placebo-controlled parallel group, dose-ranging Phase IIb clinical trial. The Company has commenced a Phase III clinical trial of EVK-001 in female patients with symptoms associated with acute and recurrent diabetic gastroparesis. The Phase III clinical trial is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study evaluating the efficacy, safety and population pharmacokinetics of EVK-001 in adult females.
MORE >

Recently

Name
Price
%Change